These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 9200535)

  • 21. Therapeutic choices in reflux disease: defining the criteria for selecting a proton pump inhibitor.
    Freston JW
    Am J Med; 2004 Sep; 117 Suppl 5A():14S-22S. PubMed ID: 15478848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacokinetics of lansoprazole.
    Landes BD; Petite JP; Flouvat B
    Clin Pharmacokinet; 1995 Jun; 28(6):458-70. PubMed ID: 7656504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical pharmacological aspects of the proton pump inhibitor therapy: importance of pharmacogenetic differences in the clinical practice].
    Mullner K; Molnar B; Tulassay Z
    Orv Hetil; 2007 Mar; 148(12):543-51. PubMed ID: 17444020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytochrome P450 2C19 genotype -based second line therapy with amoxicillin and lansoprazole after failure of initial helicobacter pylori eradication therapy].
    Asano M; Taniwaki H; Tsuji D; Sato Y; Shimizu T
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():450-3. PubMed ID: 16416832
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics of proton pump inhibitors in children.
    Litalien C; Théorêt Y; Faure C
    Clin Pharmacokinet; 2005; 44(5):441-66. PubMed ID: 15871633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-performance thin-layer chromatographic method for the detection and determination of lansoprazole in human plasma and its use in pharmacokinetic studies.
    Pandya KK; Mody VD; Satia MC; Modi IA; Modi RI; Chakravarthy BK; Gandhi TP
    J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):199-204. PubMed ID: 9200535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Andersson T
    Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lansoprazole fast disintegrating tablet: a new formulation for an established proton pump inhibitor.
    Baldi F; Malfertheiner P
    Digestion; 2003; 67(1-2):1-5. PubMed ID: 12743433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dosaging of proton pumps inhibitors].
    Brørs O
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2397-9. PubMed ID: 16998554
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole.
    Sharma VK
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S18-21. PubMed ID: 10597120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.